Complete Androgen Insensitivity Syndrome

ST
by Stuart Taylor5 views·Updated Aug 20, 2012
Powered by AI

Need to present on this topic?

Create your own polished presentation in minutes. Just describe what you need.

Free to try, no credit card required

Transcript

  • Genetically female.
  • Presents with primary amenorrhoea like CAIS and also normal external female genitalia.
  • Normal secondary sexual characteristics.
  • Genetic condition which causes the agenesis of the mullerian ducts.
  • Most commonly caused by 21-hydroxylase deficiency.
  • Milder cases may present later in life with primary amenorrhoea.
  • Unlikely due to presence of other hormonal imbalances that would be noticeable.

References

6. Michala L, Goswami D, Creighton SM, Conway GS. Swyer syndrome: presentation and outcomes. BJOG : an international journal of obstetrics and gynaecology. 2008;115(6):737-41. Epub 2008/04/16.

7. Morcel K, Camborieux L, Guerrier D. Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Orphanet journal of rare diseases. 2007;2:13. Epub 2007/03/16.

8. Mustafa R, Hashmi HA, Baqai Z. Complete androgen insensitivity syndrome in an X Y female. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 2006;16(8):563. Epub 2006/08/11.

9. Okada T, Sasaki S, Honda S, Miyagi H, Minato M, Todo S. Irreducible indirect inguinal hernia containing uterus, ovaries, and Fallopian tubes. Hernia : the journal of hernias and abdominal wall surgery. 2011. Epub 2011/01/08.

1. Gottlieb B, Beitel LK, Trifiro MA. Androgen Insensitivity Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. Seattle (WA)1993.

2. Holmes-Walker DJ, Conway GS, Honour JW, Rumsby G, Jacobs HS. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinical endocrinology. 1995;43(3):291-6. Epub 1995/09/01.

3. Hughes IA, Deeb A. Androgen resistance. Best practice & research Clinical endocrinology & metabolism. 2006;20(4):577-98. Epub 2006/12/13.

4. Kumar P, Clarks M. Kumar & Clark’s Clinical Medicine. Seventh ed. Edinburgh: Elsevier; 2009. p 1360. pg. 1014

5. Mallin SR. Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency. Two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries. Annals of internal medicine. 1969;70(1):69-75. Epub 1969/01/01.

Introduction

Complete Androgen

Insensitivity in Males

  • Scale of disease from mild to complete.
  • Is present in males with 46 XY genotype.
  • Is difficult to diagnose because of the lack of symptoms.

By Stuart Taylor and Sean McKeon

In the

Clinic

  • Occurs in genetic males.
  • Other name for condition is 'Pure gonadal dysgenesis'.
  • Patients typically have normal external genitalia and Mullerian ducts.
  • Gonads are defective and cannot produce oestrogens which is only detected at puberty.

Mullerian Agenesis-MRKH

Swyer Syndrome

Congenital Adrenal Hyperplasia

Signs

Symptoms

Treatment /Management

Amenorrhoea and

delayed puberty

Branches

Symptom

Surgery

Amenorrhoea + delayed puberty

(cc) photo by theaucitron on Flickr

Abnormal

Swelling

Psychological

  • Primary amenorrhoea as patient has never menstruated.
  • Differentials of amenorrhoea may be:
  • Primary ovarian failure
  • Decrease in gonadotrophin levels

Scanty pubic hair

Striking, tall and lean

Structural

defects

Lack of Axillary hair?

HRT

  • Abnormal swelling of the labia in the female.
  • Differentials:
  • Testicular herniation
  • Inguinal bowel herniation
  • Irritation or infection

Differential Diagnosis Tree

  • Absence of female internal duct system which includes the uterus, ovaries and fallopian tube.
  • 'Short' vagina 2" in depth compared to 3 to 4" and is blind ended.
  • Presence of testes located in the abdomen.
  • May be more likely a sign than a symptom.
  • Women unlikely to complain that they haven't got hairy armpits.

Sometimes abnormal characteristics due to hormonal genetic differences.

How is the condition diagnosed?

Types of Androgen Insensitivity Syndrome- and why there are different types

  • Fig. 1. Schematic representation of a grading scheme for clinical classification of AIS. Grades are numbered I through 7 in order of increasing severity (more defective masculinization). Grade 1: normal masculinization in utero; grade 2: male phenotype with mild defect in masculinization (e.g., isolated hypospadias); grade 3: male phenotype with severe defect in masculinization—small penis, perineoscrotal hypospadias, bifid scrotum or cryptorchidism; grade 4: severe genital ambiguity— clitoral-like phallus, labioscrotal folds, single perineal orifice; grade 5: female phenotype with posterior labial fusion and clitoromegaly; grade 6/7: female phenotype (grade 6 if pubic hair present in adulthood, grade 7 if no pubic hair in adulthood). (Adapted from Quigley CA, DeBellis A, Marschke KB, El-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Rev 1995; 1 6(3):282; with permission.)
  • Complete androgen insensitivity syndrome (CAIS): typical female external genitalia present
  • Partial androgen insensitivity syndrome (PAIS): predominantly female, predominantly male or ambiguous external genitalia
  • Mild androgen insensitivity syndrome (MAIS): typical male external genitalia
  • Analysis of the following may occur:
  • Karyotype test or fluorescent in situ hybridization
  • Levels of testosterone and

dihydrotestosterone (DHT)

  • Mutation analysis of the

androgen receptor gene

What happens after diagnosis-Treatment options

  • Surgery- usually gonadectomy/orchidectomy (uncertainty over best timing), vaginal lengthening procedures, cosmetic genital reconstructive surgery.
  • HRT- hormone replacement therapy: CAIS= oestrogen replacement, initial low dose, progesterone if appropriate, PAIS= same treatment if female identity, if male DHT may be administered.
  • Psychological support- most important aspect from patient’s perspective. Parental support and genetic counselling can also be given. Primary care practitioner or pediatric endocrinologist can coordinate care as part of multi-disciplinary team.